|
Drugs and Devices Today - Web Exclusives

FDA approves Marqibo for rare type of leukemia

Issue Date: August 2012 Vol. 7 No. 7

0 Comments


On Aug. 9, the U.S. Food and Drug Administration (FDA) approved Marqibo (vincristine sulfate liposome injection) to treat adults with Philadelphia chromosome negative (Ph-) acute lymphoblastic leukemia (ALL). Read more.

No Comments.